• Corporate
  • Corporate Profile
  • Business
  • Corporate History
• Products & Services
  • Products
    • Kinase Proteins
    • Biotinylated Kinases
    • Kinase Protein Assay Kits
    • Substrates
    • Stable Cell Lines
  • Services
    • Profiling Services
    • NanoBRET™ TE Intracellular Kinase Cell-Based Assay Services
    • Protein-Protein Interactions
    • Live-cell Kinase Assays
    • ClariCELL™ Kinase
      Cell-Based Assay Services
    • Crystallization Services
    • Custom Production of Ultra-Pure Proteins for Crystallography
    • Weak Affinity Chromatography (WAC™)
  • Pricing & Technical Inquiry
• Drug Discovery
  • Our Technologies
  • Pipeline
  • Partnering
  • Publications
• IR
  • IR News
  • Financial Highlights
  • IR Library
  • IR Calendar
  • Stock Information
  • Stock Quote
  • Contact Us (IR only)

• Products & Services
• Drug Discovery

What's New

• Mar 30, 2020 IR Updated pipeline.
• Mar 16, 2020 IR "Carna Biosciences Announces License Agreement with BioNova Pharmaceuticals to Develop and Commercialize AS-1763 in Greater China" in IR Library.
• Feb 13, 2020 IR "Financial Results FY2019" in IR Library.
• Feb 07, 2020 IR "Consolidated Financial Results for the Year Ended December 31, 2019" in IR Library.
• Feb 04, 2020 IR "Carna announces clearance of CTA to initiate clinical trial of AS-0871" in IR Library.